Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
-0.63%
3-Month Return
+17.43%
12-Month Return
+86.42%
Volatility Score
2.7
RSI
61.1
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $438B | +28.71% | +23.91% | +0.67% | 2.6 | Up | Up |
| AMGN | Amgen | $226B | +50.74% | +26.73% | +14.81% | 2.8 | Up | Up |
| GILD | Gilead Sciences | $165B | +13.33% | +1.98% | +2.49% | 3.0 | Neutral | Neutral |
| VRTX | Vertex Pharma | $133B | +39.91% | +21.89% | +7.94% | 2.8 | Up | Up |
| REGN | Regeneron Pharma | $83B | +48.82% | +13.20% | +21.60% | 2.6 | Up | Up |
| NTRA | Natera | $46B | +102.72% | +63.90% | +17.93% | 4.2 | Up | Up |
| RVMD | REVOLUTION MEDIC | $44B | +496.46% | +45.95% | +10.75% | 3.7 | Up | Up |
| BIIB | Biogen | $31B | +61.82% | +7.07% | +4.01% | 4.0 | Neutral | Up |
| INSM | Insmed | $29B | +19.36% | +32.96% | +16.56% | 4.2 | Up | Down |
| ALNY | Alnylam Pharma | $29B | -50.12% | -26.46% | -27.37% | 6.8 | Down | Down |
| ROIV | ROIVANT SCIENCES | $26B | +220.32% | +25.28% | -0.53% | 3.5 | Up | Up |
| INCY | Incyte | $25B | +53.49% | +23.33% | +4.15% | 3.4 | Up | Up |
| MRNA | MODERNA | $24B | +134.83% | +10.05% | -12.39% | 5.7 | Neutral | Up |
| UTHR | United Therapeut | $23B | +76.30% | -6.24% | -3.18% | 2.6 | Down | Neutral |
| NBIX | Neurocrine Biosc | $17B | +33.02% | +8.32% | -6.88% | 3.6 | Down | Up |
| BBIO | BRIDGEBIO PHARMA | $17B | +75.52% | +25.64% | -1.42% | 3.2 | Up | Up |
| BMRN | Biomarin Pharm | $13B | +21.27% | +27.41% | +16.51% | 2.7 | Up | Up |
| EXEL | Exelixis | $13B | +41.57% | +9.97% | -6.27% | 3.4 | Down | Up |
| ARWR | Arrowhead Phrmct | $12B | +413.25% | +21.52% | +15.62% | 4.7 | Up | Up |
| MDGL | Madrigal Pharmct | $12B | +47.45% | +1.04% | -3.98% | 4.6 | Neutral | Neutral |
| SMMT | SUMMIT THERAP | $12B | -47.36% | -17.75% | -2.49% | 5.7 | Up | Down |
| HALO | Halozyme Therape | $12B | +63.17% | +60.04% | +34.67% | 3.0 | Up | Up |
| CYTK | Cytokinetics | $11B | +133.19% | +0.75% | -8.70% | 3.9 | Down | Up |
| PRAX | PRAXIS PRECIS | $10B | +716.37% | +11.19% | +12.91% | 5.4 | Up | Up |
| APGE | APOGEE THERAP | $10B | +288.60% | +62.17% | +0.75% | 0.2 | Up | Up |
| KRYS | KRYSTAL BIOTECH | $9.8B | +141.09% | +8.47% | -9.35% | 5.3 | Down | Up |
| PTGX | Protagonist Ther | $9.7B | +179.07% | +50.97% | +14.14% | 4.1 | Up | Up |
| IONS | Ionis Pharmaceut | $9.5B | +39.42% | -24.79% | -2.25% | 3.6 | Down | Down |
| SYRE | Spyre Therap | $9.3B | +590.69% | +40.36% | +7.77% | 6.1 | Up | Up |
| KYMR | KYMERA THERAP | $9B | +188.16% | +26.14% | -9.02% | 4.3 | Up | Up |
| PCVX | VAXCYTE | $8.7B | +96.46% | +9.96% | +0.14% | 4.0 | Up | Up |
| ALKS | Alkermes | $8.3B | +86.13% | +41.18% | -4.89% | 3.7 | Neutral | Up |
| IMVT | IMMUNOVANT | $8.2B | +170.26% | +37.84% | +0.45% | 3.7 | Up | Up |
| RYTM | RHYTHM PHARM | $8B | +22.45% | +22.63% | +6.53% | 4.1 | Up | Up |
| IBRX | IMMUNITYBIO | $7.9B | +203.24% | -11.99% | -8.88% | 5.7 | Down | Up |
| TWST | TWIST BIOSCIENCE | $7.8B | +351.97% | +119.67% | +37.78% | 6.4 | Up | Up |
| TGTX | TG Therap | $7.5B | +86.28% | +14.70% | -13.94% | 4.8 | Down | Up |
| COGT | COGENT BIOSCIS | $7.1B | +279.96% | +19.55% | +6.84% | 4.8 | Up | Up |
| CGON | CG ONCOLOGY | $6.8B | +219.73% | +9.97% | +1.75% | 4.8 | Up | Up |
| ORKA | ORUKA THERA | $6.3B | +705.67% | +62.78% | +21.14% | 5.1 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |